This is Your Brain on DREADDs
Chemogenetics Provides a Noninvasive Tool for Precise Control of Neural Circuits
GEN Roundup: Multiplexed Immunoassays: Small Samples, Big Pictures
Taking in "Everything All at Once" Can Reveal Meaningful Biological Patterns and Drug Targets
10 Takeover Targets to Watch This Fall
Pace of Biopharma M&A Slows from First Half Stampede of Deals
Scaling Up Cell Therapy Manufacturing
Moving Forward with an Early-on Strategy
For full access to this article login to GEN Select now.
Peptide Therapeutics Near the Sweetest Spots
Advantages May Place Peptides Ahead of Small-Molecule Drugs
- Peptide therapeutics would seem to occupy a sweet spot between small molecules and biologics. Small molecules, which represent the majority of clinical drugs, preferentially bind hydrophobic pockets or cavities, but targeting them to protein interfaces that are large or shallow, or contain combinations of polar and apolar residues, is ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.